VMPL New Delhi [India] January 31 Allergic rhinitis is a very common condition often termed as hay fever which affects millions of people globally This chronic condition arises from the reaction of th ...

Diag-Nose Team Photo RhinoMAP platform Diag-Nose secures $2M to advance AI in respiratory care, aiming to optimize global <a target= ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...

Diag-Nose.io sets new standards in respiratory care with AI and proteomics after a $2M seed funding success, now expanding to Bethlehem, PABETHLEHEM, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- A ...

The Victorian Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

The global sinusitis treatment market is witnessing steady growth, fueled by the increasing prevalence of sinus infections, ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

A Victorian-based company is using AI to help “map” and personalise the best treatment for patients with respiratory ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...